The realization that autoantibodies can contribute to dysfunction of the brain has brought
about a paradigm shift in neurological diseases over the past decade, offering up important …

Objective To define the clinical characteristics, management, and outcome of neurologic
immune-related adverse events (n-irAEs) of immune checkpoint inhibitors (ICIs). Methods …

Expanding use of immune‐checkpoint inhibitors (ICIs) underscores the importance of
accurate diagnosis and timely management of neurological immune‐related adverse events …

Objective To describe neural autoantibody profiles and outcomes in patients with neurologic
autoimmunity associated with immune checkpoint inhibitor (ICI) cancer immunotherapy …

Antibody-mediated disorders of the central nervous system (CNS) are increasingly
recognized as neurologic disorders that can be severe and even life-threatening but with the …

Objective To describe the spectrum and outcome of central nervous system complications
associated with immune checkpoint inhibitors (CNS-ICI). Methods Patients with CNS-ICI …

We provide an overview of the varied presentations of paraneoplastic neurological
syndromes. We also review the onconeural antibodies and their particular oncological and …

Paraneoplastic neurological syndromes (PNS) include any symptomatic and non-metastatic
neurological manifestations associated with a neoplasm. PNS associated with antibodies …

Abstract Purpose of Review To provide an overview and highlight recent updates in the field
of paraneoplastic neurologic disorders. Recent Findings The prevalence of paraneoplastic …

Autoimmune chorea syndromes represent a vast array of paraneoplastic, parainfectious and
idiopathic disorders. It is increasingly apparent that familiarity with these disorders is …